FFO
CDLX icon

Fortitude Family Office’s Cardlytics CDLX Stock Holding History

Fortitude Family Office’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28
Closed -$671 – 1949
2025
Q3 		$671 Buy
+28
New +$466 ﹤0.01% 1695

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fortitude Family Office's CDLX Position: Q4 2025 in Review

Fortitude Family Office sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 28 shares — an estimated $671 sold.

Fortitude Family Office first reported a position in CDLX in Q3 2025 and held it in 1 quarter. The position peaked at $671 in Q3 2025. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • Fortitude Family Office reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 28 Cardlytics shares in Q4 2025, an estimated $671.
  • Fortitude Family Office first reported a position in Cardlytics in Q3 2025 and held it in 1 quarter.
  • Fortitude Family Office's Cardlytics position peaked at $671 in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.